Operating Lease, Right-of-Use Asset of Cidara Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cidara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Cidara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,795,000, a 41% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,795,000 -$1,240,000 -41% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,120,000 -$1,201,000 -36% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $2,435,000 -$1,164,000 -32% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $2,739,000 -$1,049,000 -28% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $3,035,000 -$1,015,000 -25% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $3,321,000 -$986,000 -23% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $3,599,000 +$2,763,000 +331% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $3,788,000 +$2,689,000 +245% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $4,050,000 +$2,696,000 +199% 30 Sep 2023 10-K 22 Apr 2024 2023 FY
Q2 2023 $4,307,000 +$2,705,000 +169% 30 Jun 2023 10-K 22 Apr 2024 2023 FY
Q1 2023 $836,000 -$1,010,000 -55% 31 Mar 2023 10-K 22 Apr 2024 2023 FY
Q4 2022 $1,099,000 -$1,188,000 -52% 31 Dec 2022 10-K 22 Apr 2024 2023 FY
Q3 2022 $1,354,000 -$1,186,000 -47% 30 Sep 2022 10-K 22 Apr 2024 2023 FY
Q2 2022 $1,602,000 +$1,156,000 +259% 30 Jun 2022 10-K 22 Apr 2024 2023 FY
Q1 2022 $1,846,000 +$1,183,000 +178% 31 Mar 2022 10-K 22 Apr 2024 2023 FY
Q4 2021 $2,287,000 +$1,419,000 +163% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $2,540,000 +$1,477,000 +139% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $446,000 -$811,000 -65% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $663,000 -$784,000 -54% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $868,000 -$764,000 -47% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $1,063,000 -$747,000 -41% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,257,000 -$726,000 -37% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $1,447,000 -$684,000 -32% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $1,632,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $1,810,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $1,983,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $2,131,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.